Biofidelity. Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 72

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $24.3M

  • Investors
  • 9

Biofidelity. General Information

Description

Developer of a novel molecular assay designed to broaden access to precision testing for all patients. The company's technology can detect a single molecule of mutated DNA against the background of a large number of healthy molecules present in a typical patient sample and can be implemented on existing laboratory instrumentation with a simple workflow and sensitivity, enabling oncologists to target the right treatments at the right time.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 330 Cambridge Science Park
  • Milton Road
  • Cambridge CB4 0WN
  • England, United Kingdom
+44 01223
Primary Industry
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 330 Cambridge Science Park
  • Milton Road
  • Cambridge CB4 0WN
  • England, United Kingdom
+44 01223

Biofidelity. Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biofidelity. Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 13-Apr-2024 $24.3M Completed Generating Revenue
4. Early Stage VC (Series A1) 01-Feb-2022 Completed Generating Revenue
3. Early Stage VC (Series A) 20-Aug-2020 Completed Generating Revenue
2. Grant 10-Oct-2019 $619K $974K Completed Generating Revenue
1. Seed Round 16-May-2019 $974K $974K Completed Generating Revenue
To view Biofidelity.’s complete valuation and funding history, request access »

Biofidelity. Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-4
Series A-3
Series A-2
B Ordinary
Series A-2 2,019,769 $0.000013 $5.54 $5.54 2x $5.54 20.24%
Ordinary 477,707 $0.000013 $1.98 $1.98 1x $1.98 4.79%
To view Biofidelity.’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Biofidelity. Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a novel molecular assay designed to broaden access to precision testing for all patients. The company's tec
Biotechnology
Cambridge, United Kingdom
72 As of 2024

Cambridge, MA
 

Hilden, Germany
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Biofidelity. Competitors (4)

One of Biofidelity.’s 4 competitors is Foundation Medicine, a Formerly VC-backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Foundation Medicine Formerly VC-backed Cambridge, MA
Qiagen Formerly VC-backed Hilden, Germany
Guardant Health Formerly VC-backed Palo Alto, CA
Biocartis Formerly VC-backed Mechelen, Belgium
To view Biofidelity.’s complete competitors history, request access »

Biofidelity. Patents

Biofidelity. Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202209241-D0 Polynucleotide detection Inactive 23-Jun-2022
GB-202109111-D0 Polynucleotide detection Inactive 24-Jun-2021
GB-202109017-D0 Polynucleotide detection Inactive 23-Jun-2021
EP-4359558-A1 Polynucleotide detection Pending 23-Jun-2021
US-20240301478-A1 Polynucleotide detection Pending 23-Jun-2021 C12Q1/683
To view Biofidelity.’s complete patent history, request access »

Biofidelity. Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biofidelity. Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Octopus Ventures Venture Capital Minority
Perscitus Family Office Minority
SBI Investment Corporate Venture Capital Minority
Agilent Technologies Corporation Minority
BlueYard Capital Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Biofidelity. FAQs

  • When was Biofidelity. founded?

    Biofidelity. was founded in 2019.

  • Where is Biofidelity. headquartered?

    Biofidelity. is headquartered in Cambridge, United Kingdom.

  • What is the size of Biofidelity.?

    Biofidelity. has 72 total employees.

  • What industry is Biofidelity. in?

    Biofidelity.’s primary industry is Biotechnology.

  • Is Biofidelity. a private or public company?

    Biofidelity. is a Private company.

  • What is the current valuation of Biofidelity.?

    The current valuation of Biofidelity. is .

  • What is Biofidelity.’s current revenue?

    The current revenue for Biofidelity. is .

  • How much funding has Biofidelity. raised over time?

    Biofidelity. has raised $61.4M.

  • Who are Biofidelity.’s investors?

    Octopus Ventures, Perscitus, SBI Investment, Agilent Technologies, and BlueYard Capital are 5 of 9 investors who have invested in Biofidelity..

  • Who are Biofidelity.’s competitors?

    Foundation Medicine, Qiagen, Guardant Health, and Biocartis are competitors of Biofidelity..

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »